Lenire Tinnitus Treatment Device

22/10/2025

Neuromod is at EUHA 2025 in Nuremberg at Hall 7, Booth 228 — it's hard to miss!

Speak with our team about , the treatment device that is proven in large-scale clinical trials and with real world patients.

Visit the our booth to learn how you can offer your patients proven relief from tinnitus, hear a sample of the Lenire's audio, and find out how you can enrol in Tinnitus Masterclass from Neuromod.

21/10/2025

Lenire by Neuromod is now the highest rated available tinnitus treatment option according to Tinnitus UK's updated treatment information sheets.

Tinnitus UK's update acknowledges the expansive body of clinical trial and real world evidence for Lenire, as well as the seismic shift in attitudes towards bimodal neuromodulation as a tinnitus treatment method.

"Lenire is considered very safe, with clear evidence of effectiveness compared to no treatment – a level of efficacy currently matched only by professional cognitive behavioural therapy (CBT) and hearing aids," writes Tinnitus UK's Laura Hine. "This reflects the growing body of evidence being published that shows the efficacy not just of bimodal neuromodulation, but the Lenire® device specifically."

We're changing our treatment information sheets to better reflect the latest research evidence

21/10/2025

Neuromod Devices is proud to launch Tinnitus Masterclass, an online course that will equip hearing care professionals with the clinical and commercial knowledge to confidently introduce, or expand, tinnitus care at their clinic.

“Demand for tinnitus care from expert clinicians is significant. Building the knowledge and confidence of clinicians interested in helping tinnitus patients is critical to serving the global patient population,” said Dr. Ross O'Neill Ph. D., Neuromod Founding CEO.

“Tinnitus Masterclass delivers this by combining expertise from some of the most experienced tinnitus clinicians practising today with Neuromod’s significant experience training audiology and ENT practices in clear, practical lessons”.

Find out more about Tinnitus Masterclass by visiting Booth 228 (Hall 7) at EUHA 2025. You can also sign up on our Neuromod's website.

Neuromod launches Tinnitus Masterclass, a comprehensive online course that provides clinical and commercial expertise on tinnitus care.

21/10/2025

Neuromod Devices is proud to be part of EUHA in Nuremberg, Germany, from October 22–24.

We look forward to a few inspiring days of collaboration, innovation, and sharing global insights on advancing tinnitus care.

📍 Visit us at Booth #228 (Hall 7) to learn more about , the world’s first and only FDA-approved bimodal neuromodulation device for tinnitus.

17/10/2025

We’re thrilled to see KRDO13 News highlight how , the only FDA-approved bimodal neuromodulation device, is already helping tinnitus patients in 's only southern Colorado provider, Hearing Consultants of Colorado Springs.

The article shares how clinicians like Dr. Cassie Iliff, are using to bring hope to those living with persistent ringing in the ears, combining gentle tongue stimulation with customized sound therapy to help the brain reduce the perception of tinnitus.

COLORADO SPRINGS, Colo. (KRDO) -- There's a new The U.S. Food and Drug Administration (FDA)-approved tinnitus technology that's showing great results

13/10/2025

Prof. Hubert Lim joined the panel “Tinnitus Treatment Now and in the Future: A Multi-Faceted Discussion on What’s Next” at the American Academy of Otolaryngology – Head & Neck Surgery Annual Meeting in Indianapolis this past weekend, sharing real-world evidence on and its impact on tinnitus care.

10/10/2025

Neuromod is excited to be at the American Academy of Otolaryngology - Head & Neck Surgery Annual Meeting in Indianapolis this weekend!

Catch Neuromod's Chief Scientific Officer, Prof. Hubert Lim, on the panel “Tinnitus Treatment Now and in the Future”, Saturday, Oct 11 at 2 PM in Wabash Ballroom 3.

Looking forward to insightful discussions on the future of tinnitus care.

07/10/2025

Read "Back from the Brink" a case study about a patient with catastrophic tinnitus who no longer needed medication to regulate her sleep and mood following tinnitus treatment with .

When this patient presented to Emily E. McMahan, AuD at Alaska Hearing & Tinnitus Center, her tinnitus was 76/100 on the THI. The tinnitus was so pervasive, she experienced self-harm ideations, and was using a combination of Ambien, Zoloft, Xanax, Ativan and Lexapro to regulate sleep and mood.

Within 12-weeks of initiating treatment with Lenire, the patient's tinnitus improved so much that she was able to discontinue all medication. One year later, her THI has decreased to 16 and she now feels like she has her life back.

The patient sent her audiologist an inscribed vase with a poignant message that read: “Never give up on the hard patients as we still have beautiful work left to complete in this world.”

You can read this fascinating case report at AudiologyOnline.

As Lenire gains traction in clinical practice, real-world cases like this help clarify its role in managing complex tinnitus presentations, particularly following surgical interventions.

02/10/2025

Laura was living with assuming there was nothing that could be done. She used sound masking and hearing aids for a couple of years but it had little effect. After extensive research, Laura visited the highly recommended tinnitus expert, Dr. Melissa Wikoff, Au.D. at Peachtree Hearing.

Dr. Wikoff helped Laura understand her tinnitus and recommended . After treating her tinnitus with Lenire, Laura has her life back from tinnitus.

"It's a combination that Lenire has between the sound and the sensation on your tongue that makes the difference." said Laura.

You can find an expert tinnitus clinic near you to see if Lenire is right for you by visiting https://www.lenire.com/find-a-clinic/

29/09/2025

We’re excited to announce that Arizona Hearing Specialists is now certified to provide , the first and only -approved treatment device, in Tucson.

Dr. Evan Davies recently discussed with KGUN 9 News, sharing his optimism for the future of tinnitus treatment.

A new treatment for tinnitus is now available in Tucson, offering relief to those who experience constant ringing in their ears.

23/09/2025

Neuromod is proud to announce the receipt of Medical Device Single Audit Program (MDSAP) and EU Medical Device Regulation (MDR) certification for the Lenire tinnitus treatment device.

“Neuromod’s commitment to delivering the highest quality of patient care begins with ensuring our quality management systems are best-in-class,” said Dr. Ross O'Neill, Neuromod Founder & CEO. “MDSAP and MDR certification allows Neuromod to continue expanding Lenire's availability in Europe while positioning the company to commercialize Lenire in new geographies such as Australia, Canada, and beyond.”

In one year, Neuromod has achieved MDSAP certification, MDR approval, Health Canada approval, and TGA approval for the ground breaking tinnitus treatment device, Lenire.

You can read the full coverage over on AudiologyOnline.

Lenire made regulatory history in 2023 by becoming the first and only FDA-approved bimodal neuromodulation tinnitus treatment device.

19/09/2025

We’re thrilled to welcome Precision Hearing, among one of the first audiology clinics in the UK to be fully trained and onboarded to provide , our clinically proven tinnitus treatment device.

The team at Precision Hearing has worked closely with Neuromod Devices to complete comprehensive training, ensuring they can deliver this innovative therapy with the highest level of care.

With their commitment to excellence in audiology and patient support, we’re excited to see Precision Hearing bring to more people seeking relief from tinnitus.

You can contact Precision Hearing directly using Lenire's Find a Clinic map, https://www.lenire.com/find-a-clinic/